April 2011

CHIEF MEDICAL EDITOR'S PAGE: The Path to Progress in AMD

Robert L. Avery, MD, Associate Medical Editor and Allen C. Ho, MD, Chief Medical Editor

PENNSYLVANIA AVENUE UPDATES: What the RUC is Going On?

GEORGE A. WILLIAMS, MD

RETINA ON WALL STREET: Iridex Corporation

STEPHEN DAILY, NEWS EDITOR

CLINICAL TRIALS FOR THE RETINA SPECIALIST: Proper Documentation in Clinical Trials

ARON SHAPIRO; NOUR ZIYADEH; DAVID WATERS-HONCU; SUNITA SAIGAL; AND ASHLEY LAFOND

FELLOWS' FOCUS: The Art of Effective Patient Counseling

EUGENE A. MILDER, MD; ALLEN CHIANG, MD; PAUL S. BAKER, MD; WITH JOSEPH I. MAGUIRE, MD, AND CARL REGILLO, MD

RETINA IN THE ASC: ASC Valuation Methods

BRUCE MALLER

RETINA PEARLS: Vitrectomy and Pars Plana Baerveldt Implant for Neovascular Glaucoma

Treating complicated glaucoma from the posterior segment perspective.

ROBERT L. AVERY, MD

GLOBAL PERSPECTIVES: Brilliant Blue G for ILM Staining and Peeling

This potent stain is easy to handle and safe, with minimal side effects.

HARDY T. S. KAGIMOTO, MD; TOSHIO HISATOMI, MD; HIROSHI ENAIDA, MD; AND TATSURO ISHIBASHI, MD

SURGICAL UPDATES: Fluocinolone Acetonide Implant Exchange

Remembering a few key points can help ensure that this procedure goes smoothly.

DAVID J. JACOBS, MD; STEVEN YEH, MD; MILAN SHAH, MD; AND THOMAS ALBINI, MD

Coats Disease: Classification and Treatment

RISHAV KANSAL, BS; KIRAN TURAKA, MD; AND CAROL L. SHIELDS, MD

VEGF Trap for the Treatment of Neovascular AMD

VIEW 1 and VIEW II phase 3 studies showed the molecule to be noninferior to ranibizumab.

DAVID S. BOYER, MD

Treat and Extend: A Better Approach to Individualized Dosing for Wet AMD?

This strategy can lower the frequency of injections and the costs and anti-VEGF therapy.

OMESH P. GUPTA, MD, MBA

The Case for Judicious Use of Anti-VEGF Agents

Judicious use of anti-vascular endothelial growth factor agents is reasonable in the treatment of neovascular age-related macular degeneration.

ELIAS REICHEL, MD

Masqueraders of Age-related Macular Degeneration

A number of inherited retinal diseases phenocopy AMD.

RONY GELMAN, MD, MS, AND STEPHEN H. TSANG, MD, PHD

The Pathogenesis of Dry Age-related Macular Degeneration

Lessons learned from animal models.

FERNANDO CRUZ-GUILLOTY, PHD; JJ ECHEGARAY; AND VICTOR L. PEREZ, MD

Topical Tubulin Inhibition for Exudative AMD

A promising new approach.

CRAIG M. GREVEN, MD, FACS; MILTON BROWN, MD, PHD; PATRICIA B. WILLIAMS, PHD; SAM ENGLISH, PHD; FRANK A. LATTANZIO, PHD; AND ALI HOSSEINI, MD

Applying Genetic Risk Data to Clinical Practice

A predictive test may help in identifying the risk of developing advanced AMD.

CARL C. AWH, MD, AND BRENT ZANKE, MD

5 Questions with Kourous A. Rezaei, MD

Dr. Rezaei is an Associate Professor in the Department of Ophthalmology at Rush University Medical Center and is a partner at Illinois Retina Associates in Chicago.